Ugeskrift for laeger
-
Ugeskrift for laeger · Apr 2020
Case Reports[Fatal outcome of coronavirus disease 2019 in a previously healthy 50-year-old man].
In this case report, a 50-year-old man who had no medical history, presented with multiple cardiac arrests following a week with progressing symptoms of pneumonia. After achieving return of spontaneous circulation he presented with respiratory failure with severe hypoxia, septic shock, and multiple organ failure. ⋯ Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was later confirmed, and the presumed cause of death was SARS-CoV-2 pneumonia. In conclusion: coronavirus disease 2019 (COVID-19) can lead to a fatal outcome in younger healthy residents, who are not treated timely in case of severe symptoms like dyspnoea.
-
Ugeskrift for laeger · Apr 2020
Case Reports[Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].
During the SARS-CoV-2 pandemic, testing of suspected cases in Denmark has recently been limited to those who were critically ill. This has left an increasing number of unregistered infections in the society, obscured quantification and impacted lived lives. ⋯ Due to strategic guidelines, he was never tested for SARS-CoV-2, but the medical record was highly suspicious for infection. Besides the well-known symptoms of SARS-CoV-2, this case also reports total anosmia and ageusia.
-
This is a review of diagnostic imaging findings in coronavirus disease-2019 (COVID-19). CT findings are frequently bilateral, multilobar and peripheral ground-glass opacities with vascular enlargements. ⋯ Initially the CT can be normal, and the diagnostic performance for COVID-19 is not optimal. However, findings of characteristic ground-glass opacities during the ongoing epidemic should lead to considerations, that the patient may have COVID-19.
-
Ugeskrift for laeger · Jun 2019
Review[Simultaneous infusion of Ringer's lactate and Ringer's acetate and other drugs].
In this review, the administration of y-site infusion of crystalloid fluids such as Ringer's lactate and Ringer's acetate is discussed. Incompatibility may occur, and it can manifest as haziness, development of gas, colour change, precipitation and a decline of the concentration of the drug. It can also lead to phlebitis, pulmonary embolism and even death. Information on y-site compatibility with Ringer's lactate can be found, but there is a need for further research regarding y-site compatibility with Ringer's acetate.